Epidemiology and treatments of neuroendocrine prostate cancer in a large commercially insured population in the US
{{output}}
Background: Neuroendocrine prostate cancer (NEPC) is a highly aggressive prostate cancer (PCa) subtype diagnosed de novo or arising from neuroendocrine differentiation of adenocarcinoma following androgen deprivation therapy (ADT... ...
